Browse by UCL Departments and Centres
![[up]](/style/images/multi_up.png)
Up a levelGroup by: Author | Type
Number of items: 25.
A
|
Al Wattar, BH;
Rogozińska, E;
Vale, C;
Fisher, D;
Petersen, I;
Nicum, S;
Bannington, D;
... Freemantle, N; + view all
(2024)
Effectiveness and safety of menopause treatments: pitfalls of available evidence and future research need.
Climacteric
10.1080/13697137.2023.2297880.
(In press).
|
Astier, Clemence;
Ngo, Carine;
Colmet-Daage, Leo;
Marty, Virginie;
Bawa, Olivia;
Nicotra, Claudio;
Ngo-Camus, Maud;
... Postel-Vinay, Sophie; + view all
(2024)
Molecular profiling of biliary tract cancers reveals distinct genomic landscapes between circulating and tissue tumor DNA.
Experimental Hematology & Oncology
, 13
(1)
, Article 2. 10.1186/s40164-023-00470-7.
|
 |
B
|
Balukova, Andrea;
Bokea, Kalliopi;
Barber, Paul R;
Ameer-Beg, Simon M;
MacRobert, Alexander J;
Yaghini, Elnaz;
(2024)
Cellular Imaging and Time-Domain FLIM Studies of Meso-Tetraphenylporphine Disulfonate as a Photosensitising Agent in 2D and 3D Models.
International Journal of Molecular Sciences
, 25
(8)
, Article 4222. 10.3390/ijms25084222.
|
|
|
Brown, Nicholas F;
Murray, Elizabeth R;
Cutmore, Lauren C;
Howard, Philip;
Masterson, Luke;
Zammarchi, Francesca;
Hartley, John A;
... Marshall, John F; + view all
(2024)
Integrin-αvβ6 targeted peptide-toxin therapy in a novel αvβ6-expressing immunocompetent model of pancreatic cancer.
Pancreatology
10.1016/j.pan.2024.02.013.
(In press).
|
|
D
|
Dillon, Magnus T;
Guevara, Jeane;
Mohammed, Kabir;
Patin, Emmanuel C;
Smith, Simon A;
Dean, Emma;
Jones, Gemma N;
... Harrington, Kevin J; + view all
(2024)
Durable responses to ATR inhibition with ceralasertib in tumors with genomic defects and high inflammation.
Journal of Clinical Investigation
, 134
(2)
, Article e175369. 10.1172/JCI175369.
|
E
|
El-Khoueiry, AB;
Trojan, J;
Meyer, T;
Yau, T;
Melero, I;
Kudo, M;
Hsu, C;
... Sangro, B; + view all
(2024)
Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040.
Annals of Oncology
10.1016/j.annonc.2023.12.008.
(In press).
|
 |
F
|
Fittall, MW;
Brewer, M;
de Boisanger, J;
Kviat, L;
Babiker, A;
Taylor, H;
Saran, F;
... Rosenfelder, N; + view all
(2024)
Predicting Survival with Brain Metastases in the Stereotactic Radiosurgery Era: are Existing Prognostic Scores Still Relevant? Or Can we do Better?
Clinical Oncology
10.1016/j.clon.2024.01.037.
(In press).
|
|
G
|
Geukens, Tatjana;
Maetens, Marion;
Hooper, Jody E;
Oesterreich, Steffi;
Lee, Adrian;
Miller, Lori;
Atkinson, Jenny M;
... Desmedt, Christine; + view all
(2024)
Research autopsy programmes in oncology: shared experience from 14 centres across the world.
The Journal of Pathology
10.1002/path.6271.
(In press).
|
|
|
Gong, Grace Q;
Vanhaesebroeck, Bart;
(2024)
Precision Targeting of Mutant PI3Kα.
Cancer Discovery
, 14
(2)
pp. 204-207.
10.1158/2159-8290.cd-23-1392.
|
J
|
Jahangir, CA;
Page, DB;
Broeckx, G;
Gonzalez, CA;
Burke, C;
Murphy, C;
Reis-Filho, JS;
... Ribeiro, JM; + view all
(2024)
Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer.
The Journal of Pathology
10.1002/path.6238.
(In press).
|
|
Janku, Filip;
Choong, Grace M;
Opyrchal, Mateusz;
Dowlati, Afshin;
Hierro, Cinta;
Rodon, Jordi;
Wicki, Andreas;
... Adjei, Alex A; + view all
(2024)
A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhibitor Bimiralisib in Patients with Advanced Solid Tumors.
Cancers
, 16
(6)
, Article 1137. 10.3390/cancers16061137.
|
|
L
|
Lau, Chun Hang;
Rouhani, Maral J;
Maughan, Elizabeth F;
Orr, Jessica C;
Kolluri, Krishna K;
Pearce, David R;
Haughey, Elizabeth K;
... Hynds, Robert E; + view all
(2024)
Lentiviral expression of wild-type LAMA3A restores cell adhesion in airway basal cells from children with epidermolysis bullosa.
Molecular Therapy
10.1016/j.ymthe.2024.02.032.
(In press).
|
|
|
Ledermann, JA;
Matias-Guiu, X;
Amant, F;
Concin, N;
Davidson, B;
Fotopoulou, C;
González-Martin, A;
... Fagotti, A; + view all
(2024)
ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.
Annals of Oncology
, 35
(3)
pp. 248-266.
10.1016/j.annonc.2023.11.015.
|
M
|
Mahmood, Umair;
Muhamad Faizul, Elisya;
Howlett, Sarah;
Amin, Zahir;
Hochhauser, Daniel;
Shiu, Kai-Keen;
Bridgewater, John;
(2024)
Comprehensive Examination of Cholangiocarcinoma Patients Treated with Novel Targeted Therapies after Extended Molecular Profiling on Liquid Biopsies.
Cancers
, 16
(4)
, Article 697. 10.3390/cancers16040697.
|
|
|
Mehanna, Hisham;
Gaunt, Piers;
Kong, Anthony;
Hartley, Andrew;
Sanghera, Paul;
Forster, Martin;
Sen, Mehmet;
... Nankivell, Paul; + view all
(2024)
CompARE: study protocol for a phase III randomised controlled platform trial comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer.
Trials
, 25
(1)
, Article 50. 10.1186/s13063-023-07881-1.
|
|
Memon, D;
Schoenfeld, AJ;
Ye, D;
Fromm, G;
Rizvi, H;
Zhang, X;
Keddar, MR;
... Hellmann, MD; + view all
(2024)
Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer.
Cancer Cell
, 42
(2)
pp. 209-224.
10.1016/j.ccell.2023.12.013.
|
|
N
|
Nicum, Shibani;
McGregor, Naomi;
Austin, Rachel;
Collins, Linda;
Dutton, Susan;
McNeish, Iain;
Glasspool, Rosalind;
... Mansouri, Anita; + view all
(2024)
Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer.
British Journal of Cancer
10.1038/s41416-023-02567-6.
(In press).
|
|
Noorani, Imran;
Luebeck, Jens;
Rowan, Andrew;
Gronroos, Eva;
Barbe, Vittorio;
Fabian, Mark;
Nicoll, James;
... Swanton, Charles; + view all
(2024)
Oncogenic extrachromosomal DNA identification using whole-genome sequencing from formalin-fixed glioblastomas.
Annals of Oncology
10.1016/j.annonc.2024.03.008.
(In press).
|
P
|
Pan, Xiaoxi;
AbdulJabbar, Khalid;
Coelho-Lima, Jose;
Grapa, Anca-Ioana;
Zhang, Hanyun;
Cheung, Alvin Ho Kwan;
Baena, Juvenal;
... Moore, David A; + view all
(2024)
The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma.
Nature Cancer
10.1038/s43018-023-00694-w.
|
Q
|
Qin, Xiao;
Tape, Christopher J;
(2024)
Functional analysis of cell plasticity using single-cell technologies.
Trends in Cell Biology
10.1016/j.tcb.2024.01.006.
(In press).
|
|
R
|
Roncolato, Felicia;
King, Madeleine T;
O'Connell, Rachel L;
Lee, Yeh Chen;
Joly, Florence;
Hilpert, Felix;
Lanceley, Anne;
... Friedlander, Michael; + view all
(2024)
Hidden in plain sight - Survival consequences of baseline symptom burden in women with recurrent ovarian cancer.
Gynecologic Oncology
, 185
pp. 128-137.
10.1016/j.ygyno.2024.02.025.
|
|
S
|
Shawe-Taylor, Marianne;
Greenwood, David;
Hobbs, Agnieszka;
Dowgier, Giulia;
Penn, Rebecca;
Sanderson, Theo;
Stevenson-Leggett, Phoebe;
... Wall, Emma C; + view all
(2024)
Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign.
The Lancet
, 403
(10432)
pp. 1133-1136.
10.1016/S0140-6736(24)00316-7.
|
|
Suddle, Abid;
Reeves, Helen;
Hubner, Richard;
Marshall, Aileen;
Rowe, Ian;
Tiniakos, Dina;
Hubscher, Stefan;
... Meyer, Tim; + view all
(2024)
British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults.
Gut
10.1136/gutjnl-2023-331695.
(In press).
|
|
|
Sweeney, Christopher J;
Hainsworth, John D;
Bose, Ron;
Burris, Howard A;
Kurzrock, Razelle;
Swanton, Charles;
Friedman, Claire F;
... Meric-Bernstam, Funda; + view all
(2024)
MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2–Altered Advanced Solid Tumors.
Journal of Clinical Oncology
, 42
(3)
pp. 258-265.
10.1200/JCO.22.02636.
|
|
Z
|
Zammarchi, Francesca;
Havenith, Karin E;
Sachini, Nikoleta;
Janghra, Narinder;
Chivers, Simon;
Idusogie, Esohe;
Gaudio, Eugenio;
... Van Berkel, Patrick H; + view all
(2024)
ADCT-602, a Novel PBD Dimer–containing Antibody–Drug Conjugate for Treating CD22-positive Hematologic Malignancies.
Molecular Cancer Therapeutics
OF1-OF12.
10.1158/1535-7163.MCT-23-0506.
(In press).
|
|
